Table 3 Univariate and multivariate logistic regression analyses for HPV-associated risk factors 50 study men who have sex with men (MSM) living in Bamako, Mali
Any HPV | Multiple HPV | HR-HPV | Multiple HR-HPV | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Number of patients | 35 | 28 | 28 | 16 | ||||||||||||||||
Risk factors | n (%) | cOR (95%CI) | P* | aOR (95%CI) | P* | n (%) | cOR (95%CI) | P* | aOR (95%CI) | P* | n (%) | cOR (95%CI) | P* | aOR (95%CI) | P* | n (%) | cOR (95%CI) | P* | aOR (95%CI) | P* |
Age (years) | ||||||||||||||||||||
18–19 | 7 (20.0) | 1 | 0.734 | NA | NA | 5 (17.9) | 1 | 0.277 | NA | NA | 5 (17.9) | 1 | 0.838 | NA | NA | 2 (12.5) | 1 | 0.192 | NA | NA |
20–29 | 23 (65.7) | 2.4 (0.6–8.6) | 19 (67.8) | 2.4 (0.7–8.5) | 19 (67.8) | 2.4 (0.7–8.5) | 12 (75.0) | 3.3 (0.7–16.6) | ||||||||||||
≥ 30 | 5 (14.3) | 1.2 (0.3–4.9) | 4 (14.3) | 1.4 (0.4–5.7) | 4 (14.3) | 1.4 (0.4–5.7) | 2 (12.5) | 1.7 (0.3–9.9) | ||||||||||||
HIV-1 infection | 14 (40.0) | 4.3 (1.2–15.2) | 0.022 | 3.1 (0.6–17.3) | 0.188 | 13 (46.4) | 5.5 (1.8–16.8) | 0.002 | 5.5 (1.3–24.5) | 0.024 | 12 (42.9) | 3.4 (1.2–9.6) | 0.022 | 3.2 (0.8–12.3) | 0.090 | 9 (56.3) | 5.0 (1.7–14.7) | 0.003 | 5.5 (1.4–21.4) | 0.014 |
Family situation | ||||||||||||||||||||
Single | 25 (71.4) | 1 | 0.138 | NA | NA | 21 (75.0) | 1 | 0.812 | NA | NA | 21 (75.0) | 1 | 0.812 | NA | NA | 12 (75.0) | 1 | 0.885 | NA | NA |
Couple | 10 (28.6) | 2.6 (0.7–9.2) | 7 (25.0) | 1.3 (0.4–3.2) | 7 (25.0) | 1.1 (0.4–3.2) | 4 (25.0) | 1.1 (0.4–3.2) | ||||||||||||
Number of sexual partners in last 6 months | ||||||||||||||||||||
1–5 | 28 (80.0) | 1 | 1.0 | NA | NA | 23 (82.1) | 1 | 0.582 | NA | NA | 23 (82.1) | 1 | 0.582 | NA | NA | 15 (93.8) | 1 | 0.058 | 1 | 0.110 |
> 5 | 7 (20.0) | 1.0 (0.3–3.2) | 5 (17.9) | 0.9 (0.7–1.9) | 5 (17.9) | 0.9 (0.7–1.9) | 1 (6.2) | 1.1 (0.2–1.5) | 1.1 (0.2–1.5) | |||||||||||
Engaged in group sex | 15 (42.9) | 3.0 (1.0–9.3) | 0.057 | NA | NA | 14 (50.0) | 4.5 (1.6–12.9) | 0.005 | 4.5 (1.1–18.1) | 0.032 | 13 (46.4) | 3.0 (1.1–8.1) | 0.035 | 2.8 (0.8–10.0) | 0.115 | 6 (37.5) | 1.1 (0.4–3.1) | 0.854 | NA | NA |
Receptive anal intercourse | 31 (88.6) | 5.2 (1.3–20.3) | 0.018 | 3.1 (0.6–15.9) | 0.178 | 25 (89.3) | 3.9 (0.9–16.2) | 0.062 | NA | NA | 24 (85.7) | 2.3 (0.6–8.6) | 0.236 | NA | NA | 15 (93.8) | 5.4 (0.7–44.8) | 0.118 | NA | NA |
Insertive anal intercourse | 25 (71.4) | 1.7 (0.5–5.3) | 0.382 | NA | NA | 23 (82.1) | 2.1 (0.7–6.3) | 0.193 | NA | NA | 21 (75.0) | 2.1 (0.7–6.7) | 0.195 | NA | NA | 10 (62.5) | 0.7 (0.2–2.2) | 0.530 | NA | NA |
Receptive oral sex | 28 (80.0) | 3.5 (1.1–11.5) | 0.038 | 1.9 (0.4–8.4) | 0.417 | 23 (82.1) | 3.2 (1.0–10.5) | 0.057 | NA | NA | 22 (78.6) | 2.1 (0.7–6.7) | 0.211 | NA | NA | 14 (87.5) | 3.8 (0.8–18.4) | 0.094 | NA | NA |
Insertive oral sex | 29 (82.9) | 0.4 (0.1–3.0) | 0.335 | NA | NA | 25 (89.3) | 1.9 (0.4–8.8) | 0.438 | NA | NA | 25 (89.3) | 1.9 (0.4–8.8) | 0.438 | NA | NA | 14 (87.5) | 1.2 (0.2–6.6) | 0.828 | NA | NA |
STI gonorrhea or Chlamydia | 16 (45.7) | 2.3 (0.8–6.8) | 0.125 | NA | NA | 13 (46.4) | 1.9 (0.7–4.9) | 0.209 | NA | NA | 12 (42.9) | 1.31 (0.5–3.4) | 0.577 | NA | NA | 8 (50.0) | 1.8 (0.7–5.1) | 0.247 | NA | NA |